Literature DB >> 9563958

Inflammatory process complicating giant hemangioma of the liver: report of three cases.

B Pol1, P Disdier, Y P Le Treut, P Campan, J Hardwigsen, P J Weiller.   

Abstract

Three cases of giant hemangioma of the liver associated with clinical and laboratory signs of inflammatory process, including low-grade fever, weight loss, abdominal pain, accelerated erythrocyte sedimentation rate, anemia, thrombocytosis, and increased fibrinogen level with normal white blood cell count are described. One patient presented with slight cholestatic jaundice because of tumor-related bile duct compression, but the other two patients had normal liver function tests, except for a slight increase in gammaglutamyl transferase. Clinical and laboratory abnormalities disappeared after surgical excision. Inflammatory manifestations have rarely been reported during giant liver hemangioma. Intratumoral inflammation necrosis or bleeding could explain the symptoms but histological signs of inflammation were not detected in two of three surgical specimens. The release of immune mediators by liver endothelial cells lining the hemangioma is an alternative explanation. The incidence of inflammatory process complicating giant hemangioma is probably underestimated because our three cases were observed within a span of only 3 years. Copyright 1998 W.B. Saunders Company.

Entities:  

Mesh:

Year:  1998        PMID: 9563958     DOI: 10.1002/lt.500040306

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  3 in total

Review 1.  Imaging of hepatic hemangioma: from A to Z.

Authors:  Giuseppe Mamone; Ambra Di Piazza; Vincenzo Carollo; Christine Cannataci; Kelvin Cortis; Tommaso Vincenzo Bartolotta; Roberto Miraglia
Journal:  Abdom Radiol (NY)       Date:  2020-03

2.  Atypical giant haemangioma of liver with systemic inflammatory manifestations.

Authors:  Mohd Khalid; Mehtab Ahmad; Amit Jain; Imran Rizvi
Journal:  BMJ Case Rep       Date:  2013-01-25

3.  A liver lesion with systemic inflammatory manifestations.

Authors:  Abhishek Agarwal; Nitin Relia; Meghana Bansal; Sara G Tariq
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.